Related Experiment Video
Updated: Jun 20, 2026
11:49
Quantitative and Temporal Control of Oxygen Microenvironment at the Single Islet Level
Published on: November 17, 2013
Improved oxygenation and hemocompatibility for microfluidic artificial lung via membrane microstreaming.
Anthony Mercader1, Sang-Ho Ye2, William R Wagner2
1Department of Mechanical Engineering and Materials Science, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Lab on a Chip
|June 19, 2026
Summary
This study introduces acoustic microstreaming to enhance microfluidic artificial lungs, improving oxygen gas exchange and reducing blood clotting and biofouling. This innovation allows for taller channels, simplifying fabrication and increasing device efficiency.
Area of Science:
- Biomedical Engineering
- Microfluidics
- Biomaterials
Background:
- Microfluidic artificial lungs offer high surface-area-to-volume ratios for efficient gas exchange.
- Challenges include coagulation, channel blockage, and scalability issues at microscale.
- Current designs often require small channel heights, limiting fabrication and throughput.
Purpose of the Study:
- To enhance gas exchange efficiency in microfluidic artificial lungs.
- To mitigate biofouling and coagulation issues.
- To enable the use of taller channels for improved fabrication and performance.
Main Methods:
- Integration of active mixing using acoustic microstreaming via an oscillating membrane.
- Testing with fresh ovine blood to assess biofouling, coagulation, and gas exchange.
- Comparison of actuated versus non-actuated membrane designs.
Main Results:
- Reduced platelet deposition (biofouling) on actuated membranes by up to 80%.
- Demonstrated reduction in coagulation and channel blockage in taller, actuated channels.
- Improved oxygen (O2) gas exchange by up to 2.6x compared to controls.
Conclusions:
- Acoustic microstreaming effectively enhances gas exchange and reduces biofouling in microfluidic artificial lungs.
- The design facilitates taller channel heights, simplifying fabrication and reducing coagulation.
- This approach improves device lifetime, efficiency, and scalability for artificial lung applications.
